Toll Free: 1-888-928-9744

2013-2028 Report on Global Biosimilar Monoclonal Antibodies Market by Player, Region, Type, Application and Sales Channel

Published: Jul, 2019 | Pages: 105 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Biosimilar Monoclonal Antibodies market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Biosimilar Monoclonal Antibodies from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Biosimilar Monoclonal Antibodies market.

Leading players of Biosimilar Monoclonal Antibodies including:

•	Celltrion
•	Pfizer (Hospira)
•	3SBIO
•	Novartis (Sandoz)
•	Dr Reddy's
•	Celgen Biopharma
•	Cadila Healthcare
•	Hisun Pharma
•	Torrent Pharmaceuticals

Market split by Type, can be divided into:

•	Infliximab
•	Rituximab
•	Trastuzumab
•	Adalimumab
•	Other

Market split by Application, can be divided into:

•	Oncology
•	Autoimmune Disease
•	Other

Market split by Sales Channel, can be divided into:

•	Direct Channel
•	Distribution Channel

Market segment by Region/Country including:

•	North America (United States, Canada and Mexico)
•	Europe (Germany, UK, France, Italy, Russia and Spain etc.)
•	Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
•	South America Brazil, Argentina, Colombia and Chile etc.)
•	Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.
 Table of Contents

Chapter 1 Biosimilar Monoclonal Antibodies Market Overview
    1.1 Biosimilar Monoclonal Antibodies Definition
    1.2 Global Biosimilar Monoclonal Antibodies Market Size Status and Outlook (2013-2028)
    1.3 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Region (2013-2028)
    1.4 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Type (2013-2028)
    1.5 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Application (2013-2028)
    1.6 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Sales Channel (2013-2028)
    1.7 Biosimilar Monoclonal Antibodies Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)

Chapter 2 Biosimilar Monoclonal Antibodies Market Segment Analysis by Player
    2.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Player (2016-2018)
    2.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Player (2016-2018)
    2.3 Global Biosimilar Monoclonal Antibodies Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player

Chapter 3 Biosimilar Monoclonal Antibodies Market Segment Analysis by Type
    3.1 Global Biosimilar Monoclonal Antibodies Market by Type
        3.1.1 Infliximab
        3.1.2 Rituximab
        3.1.3 Trastuzumab
        3.1.4 Adalimumab
        3.1.5 Other
    3.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
    3.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
    3.4 Global Biosimilar Monoclonal Antibodies Average Price by Type (2013-2018)
    3.5 Leading Players of Biosimilar Monoclonal Antibodies by Type in 2018
    3.6 Conclusion of Segment by Type

Chapter 4 Biosimilar Monoclonal Antibodies Market Segment Analysis by Application
    4.1 Global Biosimilar Monoclonal Antibodies Market by Application
        4.1.1 Oncology
        4.1.2 Autoimmune Disease
        4.1.3 Other
    4.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Biosimilar Monoclonal Antibodies by Application in 2018
    4.4 Conclusion of Segment by Application

Chapter 5 Biosimilar Monoclonal Antibodies Market Segment Analysis by Sales Channel
    5.1 Global Biosimilar Monoclonal Antibodies Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel

Chapter 6 Biosimilar Monoclonal Antibodies Market Segment Analysis by Region
    6.1 Global Biosimilar Monoclonal Antibodies Market Size and CAGR by Region (2013-2028)
    6.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Region (2013-2018)
    6.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Biosimilar Monoclonal Antibodies Market Share by Type
        6.4.3 North America Biosimilar Monoclonal Antibodies Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Biosimilar Monoclonal Antibodies Market Share by Type
        6.5.3 Europe Biosimilar Monoclonal Antibodies Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Type
        6.6.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Biosimilar Monoclonal Antibodies Market Share by Type
        6.7.3 South America Biosimilar Monoclonal Antibodies Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Type
        6.8.3 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Biosimilar Monoclonal Antibodies Players
    7.1 Celltrion
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Pfizer (Hospira)
    7.3 3SBIO
    7.4 Novartis (Sandoz)
    7.5 Dr Reddy's
    7.6 Celgen Biopharma
    7.7 Cadila Healthcare
    7.8 Hisun Pharma
    7.9 Torrent Pharmaceuticals

Chapter 8 Upstream and Downstream Analysis of Biosimilar Monoclonal Antibodies
    8.1 Industrial Chain of Biosimilar Monoclonal Antibodies
    8.2 Upstream of Biosimilar Monoclonal Antibodies
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Biosimilar Monoclonal Antibodies
        8.3.1 Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies
        8.3.2 Leading Consumers of Biosimilar Monoclonal Antibodies

Chapter 9 Development Trend of Biosimilar Monoclonal Antibodies (2019-2028)
    9.1 Global Biosimilar Monoclonal Antibodies Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Biosimilar Monoclonal Antibodies Market Size Forecast by Sales Channel (2019-2028)

Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification
List of Tables and Figures

    Figure Biosimilar Monoclonal Antibodies Example
    Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Biosimilar Monoclonal Antibodies Sales Comparison by Type (2013-2028)
    Figure Global Biosimilar Monoclonal Antibodies Sales Comparison by Application (2013-2028)
    Figure Global Biosimilar Monoclonal Antibodies Sales Comparison by Sales Channel (2013-2028)
    Table Global Biosimilar Monoclonal Antibodies Sales by Player (2016-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Player (2016-2018)
    Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Player in 2018
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Player (2016-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Player (2016-2018)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Player in 2018
    Table Global Biosimilar Monoclonal Antibodies Average Price by Player (2016-2018)
    Figure Global Biosimilar Monoclonal Antibodies Average Price by Player in 2018
    Figure Global Biosimilar Monoclonal Antibodies Players Competition Situation - Top 5 Players' Revenue Market Share in 2016
    Figure Global Biosimilar Monoclonal Antibodies Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Infliximab
    Figure Global Infliximab Sales and Growth Rate (2013-2018)
    Figure Example of Rituximab
    Figure Global Rituximab Sales and Growth Rate (2013-2018)
    Figure Example of Trastuzumab
    Figure Global Trastuzumab Sales and Growth Rate (2013-2018)
    Figure Example of Adalimumab
    Figure Global Adalimumab Sales and Growth Rate (2013-2018)
    Figure Example of Other
    Figure Global Other Sales and Growth Rate (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales by Type (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2018
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Type (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type in 2018
    Table Global Biosimilar Monoclonal Antibodies Average Price by Type (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Average Price by Type in 2018
    Table Leading Players of Biosimilar Monoclonal Antibodies by Type in 2018
    Figure Example of Oncology
    Figure Global Biosimilar Monoclonal Antibodies for Oncology Sales and Growth Rate (2013-2018)
    Figure Example of Autoimmune Disease
    Figure Global Biosimilar Monoclonal Antibodies for Autoimmune Disease Sales and Growth Rate (2013-2018)
    Figure Example of Other
    Figure Global Biosimilar Monoclonal Antibodies for Other Sales and Growth Rate (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales by Application (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2018
    Table Leading Consumers of Biosimilar Monoclonal Antibodies by Application in 2018
    Figure Example of Direct Channel
    Figure Global Biosimilar Monoclonal Antibodies for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Biosimilar Monoclonal Antibodies for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales by Sales Channel (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Sales Channel (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Sales Channel in 2018
    Table Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies by Sales Channel in 2018
    Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR by Region (2013-2028)
    Table Global Biosimilar Monoclonal Antibodies Sales by Region (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Region in 2018
    Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Region (2013-2018)
    Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2013-2018)
    Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region in 2018
    Table North America Biosimilar Monoclonal Antibodies Sales by Country (2013-2018)
    Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2013-2018)
    Table North America Biosimilar Monoclonal Antibodies Revenue by Country (2013-2018)
    Figure North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2013-2018)
    Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2018
    Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2018
    Figure United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure United States Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Canada Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Mexico Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Sales by Country (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Revenue by Country (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2018
    Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2018
    Figure Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Germany Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure UK Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure France Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Italy Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Russia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Spain Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Country (2013-2018)
    Figure Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Country (2013-2018)
    Figure Asia-Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2018
    Figure Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2018
    Figure China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure China Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Korea Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure India Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Australia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Biosimilar Monoclonal Antibodies Sales by Country (2013-2018)
    Figure South America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2013-2018)
    Table South America Biosimilar Monoclonal Antibodies Revenue by Country (2013-2018)
    Figure South America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2013-2018)
    Figure South America Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2018
    Figure South America Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2018
    Figure Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Brazil Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Argentina Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Colombia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Chile Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Country (2013-2018)
    Figure Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Biosimilar Monoclonal Antibodies Revenue by Country (2013-2018)
    Figure Middle East & Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2018
    Figure Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2018
    Figure Egypt Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Egypt Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure South Africa Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    Figure Nigeria Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of Celltrion
    Table Biosimilar Monoclonal Antibodies Introduction of Celltrion
    Table Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share of Celltrion (2016-2018)
    Table Industrial Chain of Biosimilar Monoclonal Antibodies
    Table Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
    Table General Manufacturing Process of Biosimilar Monoclonal Antibodies
    Table Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies
    Table Leading Consumers of Biosimilar Monoclonal Antibodies
    Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2019-2028)
    Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2019-2028)
    Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Region (2019-2028)
    Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Type (2019-2028)
    Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Application (2019-2028)
    Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Sales Channel (2019-2028) 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2500
Multi User - US $5000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify